On ECHEMI
Home > Drugs > Atrioventricular block
Atrioventricular block
Atrioventricular block refers to the process in which the impulse sent by the sinoatrial node is partially or completely, temporarily or permanently blocked in the atrioventricular connection area due to physiological or pathological reasons during the process of transmission from the atrium to the ventricle. According to the degree of block, it can be divided into three degrees: the first degree is that the atrioventricular conduction time is prolonged, but the atrial impulse can be transmitted to the ventricle; the second degree is that some impulses cannot be transmitted to the ventricle; the third degree is that all impulses cannot be transmitted to the ventricle, so it is also called complete atrioventricular block.
  • Site of disease:

    heart
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Bradycardia dizziness frequent atrial premature beats fatigue dizziness
  • Concurrent disease:

Related Drugs
Ningxinbao Capsules
Manufacturer:

Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd.

Ningxinbao Capsules
Manufacturer:

Fujian Sanming Tiantai Pharmaceutical Co., Ltd.

Ningxinbao Capsules
Manufacturer:

Chongqing KERUI Pharmaceutical (GROUP) Co., Ltd.

Ningxinbao Capsules
Manufacturer:

Tonghua Dongbao Five Medicines Co., Ltd.

Propranolol Hydrochloride Tablets
Indication: 1. As secondary prevention, to reduce the mortality of myocardial infarction. 2. Hypertension (alone or in combination with other antihypertensive drugs). 3. Exertional angina pectoris. 4. Control supraventricular tachyarrhythmias and ventricular arrhythmias, especially arrhythmias related to catecholamines or caused by digitalis. It can be used to control the ventricular rate of atrial flutter and atrial fibrillation that are not well treated with digitalis, and can also be used for refractory premature contractions to improve patients' symptoms. 5. Reduce the outflow tract pressure gradient in hypertrophic cardiomyopathy, relieve symptoms such as angina pectoris, palpitations and syncope. 6. Used in combination with receptor blockers to control tachycardia in patients with pheochromocytoma. 7. Used to control the rapid heart rate of hyperthyroidism, and can also be used to treat thyroid crisis.
Manufacturer:

Sinopharm Shantou Jinshi Pharmaceutical Co., Ltd.

Ningxinbao Capsules
Manufacturer:

Shaanxi Pharmaceutical Holding Group Shanhaidan Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.